Skip to main content
. 2014 Aug 24;19(6):452–458. doi: 10.1007/s12199-014-0405-7

Table 1.

Muscle dystrophy patients

Disease Sample no. Average of age ± SD (y.a.) Sex (male/female) Sporadic/Familial Average of onset ± SD (y.a.) Serum CK (U/ml)
DMD 5 10.4 ± 4.2 5/0 3/2 3.8 ± 1.1 9,101 ± 6,282
DMD 7 28.7 ± 1.5 7/0 7/0 3.8 ± 0.7 220 ± 126
DM1 8 59.4 ± 17.4 5/3 4/4 18.4 ± 16.9 121 ± 66
LGMD 7 50.0 ± 19.8 5/2 5/2 15.5 ± 13.9 633 ± 661
LGMAD2B 4 51.0 ± 18.2 3/1 4/0 23.0 ± 5.7 2,713 ± 2,722
FSHD 8 52.3 ± 17.3 4/4 4/4 14.4 ± 10.8 162 ± 155
BMD 4 52.0 ± 12.9 4/0 4/0 14 ± 14.6 687 ± 562
DMRV 5 39.2 ± 7.3 0/4 4/1 22.2 ± 6.2 206 ± 177

y.a years of age